A platform therapeutics company discovering small molecule drugs that target functional RNA structures to create new avenues to treat human disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/31/17 | $7,500,000 | Seed |
AbbVie Biotech Ventures Alexandria Venture Investments Dementia Discovery Fund Hatteras Venture Partners  MP Healthcare Venture Management SV Health Investors | undisclosed |
| 11/13/18 | $30,000,000 | Series A |
AbbVie Biotech Ventures Alexandria Venture Investments Amgen Business Development Dementia Discovery Fund Hatteras Venture Partners Illumina Ventures M Ventures MP Healthcare Venture Management Pappas Capital SV Health Investors | undisclosed |
| 09/27/19 | $7,800,000 |
Dementia Discovery Fund Illumina Ventures | undisclosed |
